Surveillance of adverse events following immunisation in Australia, 2023 Read more about Surveillance of adverse events following immunisation in Australia, 20231 view
Surveillance of adverse events following immunisation in Australia annual report, COVID-19 vaccines, 2022 Read more about Surveillance of adverse events following immunisation in Australia annual report, COVID-19 vaccines, 20224 views
Surveillance of adverse events following immunisation in Australia annual report, 2022. Read more about Surveillance of adverse events following immunisation in Australia annual report, 2022.9 views
Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-2022 Read more about Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-20228 views
Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022 Submitted by Jackson.young on Fri, 19/09/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022150 views
Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-2022 Read more about Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-202217 views
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study Read more about Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study10 views
Surveillance of adverse events following immunisation in Australia, 2022 Submitted by scott.mair@hea… on Thu, 08/05/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, 202268 views
Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial Read more about Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial23 views
Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia Read more about Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia34 views
